Overexpression of DRAM enhances p53-dependent apoptosis

Cancer Medicine

Volumn 2, Issue 1, 2013, Pages 1-10

  Takahashi, Masahiro ^a   Kakudo, Yuichi ^a   Takahashi, Shin ^a   Sakamoto, Yasuhiro ^a   Kato, Shunsuke ^a   Ishioka, Chikashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Apoptosis; DRAM; P53; Super p53

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; ATTENUATION; AUTOPHAGY; CONTROLLED STUDY; DNA DEGRADATION; DRAM GENE; GENE; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; S121F GENE;

EID: 84923072459     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.39     Document Type: Article

References (36)

1. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
2. Hall, P. A., D. Meek, and D. P. Lane. 1996. p53 - integrating the complexity. J. Pathol. 180:1-5.
3. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
4. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
5. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, and J. M. Trent, et al. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
6. Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:4816-4822.
7. Hermeking, H., C. Lengauer, K. Polyak, T. C. He, L. Zhang, S. Thiagalingam, et al. 1997. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1:3-11.
8. Ohki, R., J. Nemoto, H. Murasawa, E. Oda, J. Inazawa, N. Tanaka, et al. 2000. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J. Biol. Chem. 275:22627-22630.
9. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
10. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, et al. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15:3032-3040.
11. Wu, G. S., T. F. Burns, E. R. McDonald III, W. Jiang, R. Meng, I. D. Krantz, et al. 1997. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17:141-143.
12. Attardi, L. D., E. E. Reczek, C. Cosmas, E. G. Demicco, M. E. McCurrach, S. W. Lowe, et al. 2000. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14:704-718.
13. Flatt, P. M., K. Polyak, L. J. Tang, C. D. Scatena, M. D. Westfall, L. A. Rubinstein, et al. 2000. p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett. 156:63-72.
14. Lin, Y., W. Ma, and S. Benchimol. 2000. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26:122-127.
15. Oda, K., H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, et al. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102:849-862.
16. Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, et al. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058.
17. Nakano, K., and K. H. Vousden. 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7:683-694.
18. Stambolic, V., D. MacPherson, D. Sas, Y. Lin, B. Snow, Y. Jang, et al. 2001. Regulation of PTEN transcription by p53. Mol. Cell 8:317-325.
19. Anazawa, Y., H. Arakawa, H. Nakagawa, and Y. Nakamura. 2004. Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway. Oncogene 23:7621-7627.
20. Watanabe, G., S. Kato, H. Nakata, T. Ishida, N. Ohuchi, and C. Ishioka. 2009. alphaB-crystallin: a novel p53-target gene required for p53-dependent apoptosis. Cancer Sci. 100:2368-2375.
21. Kastan, M. B., and Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, et al. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
22. Tanaka, H., H. Arakawa, T. Yamaguchi, K. Shiraishi, S. Fukuda, K. Matsui, et al. 2000. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42-49.
23. Dameron, K. M., O. V. Volpert, M. A. Tainsky, and N. Bouck. 1994. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
24. Nishimori, H., T. Shiratsuchi, T. Urano, Y. Kimura, K. Kiyono, K. Tatsumi, et al. 1997. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15:2145-2150.
25. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
26. May, P., and E. May. 1999. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18:7621-7636.
27. Green, D. R., and G. Kroemer. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127-1130.
28. Saller, E., E. Tom, M. Brunori, M. Otter, A. Estreicher, D. H. Mack, et al. 1999. Increased apoptosis induction by 121F mutant p53. EMBO J. 18:4424-4437.
29. Kakudo, Y., H. Shibata, K. Otsuka, S. Kato, and C. Ishioka. 2005. Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s. Cancer Res. 65:2108-2114.
30. Crighton, D., S. Wilkinson, J. O'Prey, N. Syed, P. Smith, P. R. Harrison, et al. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:121-134.
31. Li, N., Y. Zheng, W. Chen, C. Wang, X. Liu, W. He, et al. 2007. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res. 67:11176-11185.
32. Johansson, A. C., H. Appelqvist, C. Nilsson, K. Kagedal, K. Roberg, and K. Ollinger. 2010. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 15:527-540.
33. Baehrecke, E. H. 2005. Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6:505-510.
34. Sakamoto, Y., S. Kato, M. Takahashi, Y. Okada, K. Yasuda, G. Watanabe, et al. 2011. Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126. Cancer Sci. 102:799-807.
35. Feng, Z., W. Hu, E. de Stanchina, A. K. Teresky, S. Jin, S. Lowe, et al. 2007. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67:3043-3053.
36. Maiuri, M. C., S. A. Malik, E. Morselli, O. Kepp, A. Criollo, P. L. Mouchel, et al. 2009. Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8:1571-1576.